Clinical Trial Update: Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative combination therapy with gemcitabine, cisplatin, and nab-paclitaxel for resectable cholangiocarcinoma, including intrahepa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)

Snippet

Sponsor: Emory University | Conditions: Resectable Cholangiocarcinoma, Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2025-08-15